RMTI
- Rockwell Medical, Inc.
()
Overview
Company Summary
Rockwell Medical, Inc. (RMTI) is a pharmaceutical company focused on developing and commercializing innovative therapeutic solutions for patients with kidney diseases. The company's primary focus is on iron replacement therapies and other key products to address the various aspects of kidney disease management.
Rockwell Medical primarily offers a unique iron replacement therapy called Triferic, which is specifically designed for patients undergoing hemodialysis. Triferic is administered directly into the dialysis machine during treatment, allowing for the replacement of iron and maintenance of hemoglobin levels in a controlled manner. This therapy aims to overcome the challenges associated with conventional iron replacement methods and reduce the need for frequent intravenous iron treatments.
In addition to Triferic, Rockwell Medical is also engaged in the development of other pharmaceutical products and medical devices related to dialysis and kidney disease management. These products are targeted at improving patient outcomes, enhancing convenience, and reducing healthcare costs associated with kidney disease treatment.
Overall, Rockwell Medical is dedicated to serving the needs of patients with kidney diseases by offering innovative therapies and advancing the field of nephrology through its research and development efforts.